• Explore /
  • Videos & Slides
  • / A phase 2 study of cyclophosphamide (CY), GVAX, pembrolizumab (Pembro), and stereotactic body radiation (SBRT) in patients (pts) with locally advanced pancreas cancer (LAPC).

A phase 2 study of cyclophosphamide (CY), GVAX, pembrolizumab (Pembro), and stereotactic body radiation (SBRT) in patients (pts) with locally advanced pancreas cancer (LAPC).

Abstract Video & Slides Poster

Presenter

null

Valerie Lee, MD

Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Videos & Slides Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

NCT02648282

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 4134)

DOI

10.1200/JCO.2021.39.15_suppl.4134

Abstract #

4134

Poster Bd #

Online Only

Abstract Disclosures

Similar Videos & Slides

Speaker: Todd Anthony Aguilera, MD, PhD

Speaker: Sarah E. Hoffe, MD

Speaker: Andrew Oar

Speaker: Sarah E. Hoffe, MD